What procedure must be followed if bacterial contamination is suspected in a blood product?

When bacterial contamination is suspected in a blood product, it is crucial to ensure patient safety and product integrity. The correct procedure involves testing all platelets for bacterial contamination prior to their issue. This step is vital because platelets can be at a higher risk for bacterial growth, especially when stored at room temperature, making them susceptible to contamination from skin flora or during the collection process.

By implementing routine bacterial testing before the release of platelet products, healthcare facilities can minimize the risk of transfusion-related complications that arise from contaminated products. This proactive measure is part of the standard operating procedures in blood banks and transfusion services, reflecting best practices in transfusion medicine.

Testing the blood product for viruses, administering the product immediately in a critical situation without further evaluation, or isolating the product without conducting any tests do not adequately address the potential hazards posed by bacterial contamination. Each of those actions could lead to serious consequences for the patient, highlighting the importance of proper testing protocols as the correct approach.